Biopharma Insights

ReproCell, IBM, and HNCDI Debut Pharmacology-AI to Boost Efficiency of Drug Discovery

ReproCell, a well-established life sciences company, recently revealed its latest service offering, Pharmacology-AI. This service is the result of a …

Continue ›››

Seqera Labs Joins Forces with Genomics England to Boost Genomic Medicine Research

Seqera Labs, recognized for its secure workflow orchestration software in the life sciences domain, is aligning forces with Genomics England, …

Continue ›››

FDA IND Approval of AI-derived Cancer Drug ISM3091 Marks a Milestone for Insilico Medicine

In an essential leap forward for the utilization of artificial intelligence (AI) in drug discovery, Insilico Medicine secured Investigational New …

Continue ›››

Eli Lilly Collaborates with XtalPi to Harness AI in Drug Discovery

XtalPi Inc., a company that uses artificial intelligence (AI) and automation in pharmaceutical technology, is set to collaborate with Eli …

Continue ›››

Neuralink's Journey and the Broadening Horizons of Brain-Computer Interface Technology

Neuralink, Elon Musk's brain-implant company, has just revealed that it received approval from the U.S. Food and Drug Administration (FDA) …

Continue ›››

Valo Therapeutics' Innovative Immuno-Oncology Therapy PeptiCRAd-1 Begins Human Trials

Valo Therapeutics Oy (ValoTx), a frontrunner in the development of advanced immunotherapies for cancer, has initiated its Phase I trial …

Continue ›››

How Syntekabio’s Supercomputing Enables AI-driven Drug Discovery

What is "supercomputing"? It refers to processing a massive quantity of complex data-intensive and computation-heavy problems often found in scientific …

Continue ›››

FDA Recognizes SiSaf's siRNA Therapy, SIS-101-ADO, for Autosomal Dominant Osteopetrosis Treatment

In a noteworthy development in the pharmaceutical industry, SiSaf Ltd, a renowned RNA delivery and therapeutics firm, recently announced that …

Continue ›››

LabGenius Showcases AI-Driven Antibody Discovery Platform in a T-cell Engager Demonstration

London-based LabGenius, known for its innovative approach to antibody discovery, recently revealed impressive results from its research platform demonstration project. …

Continue ›››

Bruker Acquires ZONTAL, Boosting Digital Transformation in Pharma Laboratories

The pharmaceutical industry is undergoing a significant shift as digital transformation in pharma continues to reshape the landscape. Bruker Corporation, …

Continue ›››

Advancing Cell-free Biocomputing

Researchers from the University of Minnesota have published a study in Nature Communications introducing a new biocomputing method, Transcriptional RNA …

Continue ›››

From Qubits to Cures: The Promise of Quantum Computing in Pharmaceutical Research and Development (a Realistic View)

In a recent announcement, Moderna and IBM unveiled their partnership aimed at utilizing cutting-edge technologies, such as artificial intelligence (AI) …

Continue ›››